The Australia hair loss treatment market size reached USD 133.84 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 302.61 Million by 2033, exhibiting a growth rate (CAGR) of 8.50% during 2025-2033. The market is driven by rising awareness of hair loss solutions, rising demand for efficient and non-surgical treatment, and ongoing technological advancements. Moreover, rising disposable incomes, coupled with a greater emphasis on personal grooming and aesthetics, are driving the growth of the market. Moreover, the widening availability of over-the-counter and prescription treatments are driving the growing uptake of hair loss treatments within the country, further expanding the Australia hair loss treatment market share.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 133.84 Million |
Market Forecast in 2033 | USD 302.61 Million |
Market Growth Rate (2025-2033) | 8.50% |
Rise in Demand for Non-Invasive and Natural Treatments
One of the most significant trends shaping the market is the increasing preference for non-invasive and natural therapies. Consumers are becoming more health-conscious and skeptical of surgical procedures or chemical-laden solutions. This is leading to a higher demand for products containing botanical extracts, vitamins, minerals, and biotin-infused formulations that promise hair regrowth without side effects. Moreover, therapies such as low-level laser therapy (LLLT), platelet-rich plasma (PRP) treatment, and microneedling are gaining traction due to their minimally invasive nature and increasing clinical validation. Additionally, the wellness movement across Australia is popularizing holistic treatment options, such as naturopathy and dietary-based regimens aimed at restoring hormonal balance and scalp health. Apart from this, consumers are seeking solutions that not only address hair loss but also prioritize safe, natural ingredients. Approximately 39% of Australians now actively seek out products containing natural ingredients, reflecting a broader trend towards cleaner, gentler formulations in hair care. As a result, brands are focusing on developing hair loss treatments that incorporate plant-based extracts, organic oils, and other natural compounds.
Growth in Male Consumer Segment and Changing Social Attitudes
The market is witnessing notable growth in its male consumer base, influenced by shifting societal attitudes toward grooming and personal appearance. According to a study, Australia ranks among the top countries with the highest prevalence of male hair loss, with approximately 40.8% of Australian men experiencing some degree of baldness. Historically, hair loss in men was often accepted as an inevitable part of aging, with minimal effort to seek medical intervention. However, cultural changes, coupled with the influence of social media, have led to increased awareness and a reduced stigma around aesthetic treatments for men. Younger males, particularly in urban centers, are now more proactive in addressing early signs of hair thinning, viewing it as a manageable condition rather than an irreversible trait. This shift has catalyzed the demand for both preventive and corrective treatments, including oral supplements, topical solutions, and clinic-based therapies. This, in turn, is contributing to the Australia hair loss treatment market growth. Besides this, celebrity endorsements and influencer marketing are normalizing the usage of hair restoration services, encouraging more men to explore treatment options. As the male segment becomes more engaged, brands and clinics are diversifying their offerings with targeted solutions and messaging specifically crafted to appeal to male consumers.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2025-2033. Our report has categorized the market based on product type, type, route of administration, gender, and distribution channel.
Product Type Insights:
The report has provided a detailed breakup and analysis of the market based on the product type. This includes corticosteroids, antihypertensive, topical immune-modulators, and others.
Type Insights:
A detailed breakup and analysis of the market based on the type have also been provided in the report. This includes non cicatricial (telogen effluvium, androgenetic alopecia, and alopecia areata), cicatricial, and others.
Route of Administration Insights:
The report has provided a detailed breakup and analysis of the market based on the route of administration. This includes oral and topical.
Gender Insights:
A detailed breakup and analysis of the market based on the gender have also been provided in the report. This includes male and female.
Distribution Channel Insights:
A detailed breakup and analysis of the market based on the distribution channel have also been provided in the report. This includes hospital pharmacies, retail pharmacies, and online pharmacies.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include Australia Capital Territory & New South Wales, Victoria & Tasmania, Queensland, Northern Territory & Southern Australia, and Western Australia.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Scope of the Report |
Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Product Types Covered | Corticosteroids, Antihypertensive, Topical Immune-Modulators, Others |
Types Covered |
|
Route of Administrations Covered | Oral, Topical |
Genders Covered | Male, Female |
Distribution Channels Covered | Hospital Pharmacies, Retail Pharmacies, Online Pharmacies |
Regions Covered | Australia Capital Territory & New South Wales, Victoria & Tasmania, Queensland, Northern Territory & Southern Australia, Western Australia |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: